{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:22:24Z","timestamp":1787019744448,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T00:00:00Z","timestamp":1195171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1475-2875-6-153","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T14:13:29Z","timestamp":1195222409000},"source":"Crossref","is-referenced-by-count":23,"title":["Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum"],"prefix":"10.1186","volume":"6","author":[{"given":"Anders","family":"Enevold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watoky MMM","family":"Nkya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Theisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse S","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja TR","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Staalsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor G","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ib C","family":"Bygbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alifrangis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,16]]},"reference":[{"key":"458_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1360-2276.2003.01114.x","volume":"8","author":"B Rapuoda","year":"2003","unstructured":"Rapuoda B, Ali A, Bakyaita N, Mutabingwa TK, Mwita A, Rwagacondo C, Mugisha V, Staedke S, Snow RW, Watkins WM: The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health. 2003, 8: 860-867. 10.1046\/j.1360-2276.2003.01114.x.","journal-title":"Trop Med Int Health"},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","volume":"2","author":"C Wongsrichanalai","year":"2002","unstructured":"Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR: Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002, 2: 209-218. 10.1016\/S1473-3099(02)00239-6.","journal-title":"Lancet Infect Dis"},{"key":"458_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu ABS, Naude B, Deitsch KW: Mutations in the P-falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000, 6: 861-871. 10.1016\/S1097-2765(05)00077-8.","journal-title":"Mol Cell"},{"key":"458_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1086\/514159","volume":"176","author":"CV Plowe","year":"1997","unstructured":"Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, EstradaFranco JG, Mollinedo RE, Avila JC, Cespedes JL: Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis. 1997, 176: 1590-1596.","journal-title":"J Infect Dis"},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/315731","volume":"182","author":"LK Basco","year":"2000","unstructured":"Basco LK, Tahar R, Keundjian A, Ringwald P: Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadosine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis. 2000, 182: 624-628. 10.1086\/315731.","journal-title":"J Infect Dis"},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1086\/315520","volume":"181","author":"AM Nzila","year":"2000","unstructured":"Nzila AM, Nduati E, Mberu EK, Sibley CH, Monks SA, Winstanley PA, Watkins WM: Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel\/sulfadoxine compared with the shorter-acting chlorproguanil\/dapsone on Kenyan Plasmodium falciparum. J Infect Dis. 2000, 181: 2023-2028. 10.1086\/315520.","journal-title":"J Infect Dis"},{"key":"458_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002, 185: 380-388. 10.1086\/338566.","journal-title":"J Infect Dis"},{"key":"458_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4269\/ajtmh.2003.69.247","volume":"69","author":"D Kyabayinze","year":"2003","unstructured":"Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G: Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg. 2003, 69: 247-252.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/322858","volume":"184","author":"TE Wellems","year":"2001","unstructured":"Wellems TE, Plowe CV: Chloroquine-resistant malaria. J Infect Dis. 2001, 184: 770-776. 10.1086\/322858.","journal-title":"J Infect Dis"},{"key":"458_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4269\/ajtmh.2003.69.184","volume":"69","author":"EO Ochong","year":"2003","unstructured":"Ochong EO, Van den Broek IVF, Keus K, Nzila A: Short report: Association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am J Trop Med Hyg. 2003, 69: 184-187.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00001432-200312000-00007","volume":"16","author":"WH Wernsdorfer","year":"2003","unstructured":"Wernsdorfer WH, Noedl H: Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology. Curr Opin Infect Dis. 2003, 16: 553-558. 10.1097\/00001432-200312000-00007.","journal-title":"Curr Opin Infect Dis"},{"key":"458_CR12","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/319865","volume":"183","author":"G Dorsey","year":"2001","unstructured":"Dorsey G, Kamya MR, Singh A, Rosenthal PJ: Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001, 183: 1417-1420. 10.1086\/319865.","journal-title":"J Infect Dis"},{"key":"458_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0035-9203(01)90250-0","volume":"95","author":"SA Omar","year":"2001","unstructured":"Omar SA, Adagu IS, Warhurst DC: Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?. Trans R Soc Trop Med Hyg. 2001, 95: 315-319. 10.1016\/S0035-9203(01)90250-0.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"458_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4269\/ajtmh.2003.69.558","volume":"69","author":"AA Djimde","year":"2003","unstructured":"Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y: Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg. 2003, 69: 558-563.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1179\/136485905X46441","volume":"99","author":"IF Khalil","year":"2005","unstructured":"Khalil IF, Alifrangis M, Tarimo DS, Staalso T, Satti GMH, Theander TG, Ronn AM, Bygbjerg IC: The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann Trop Med Parasitol. 2005, 99: 441-448. 10.1179\/136485905X46441.","journal-title":"Ann Trop Med Parasitol"},{"key":"458_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/500951","volume":"193","author":"D Francis","year":"2006","unstructured":"Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, Dokomajilar C, Rosenthal PJ, Dorsey G: Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis. 2006, 193: 978-986. 10.1086\/500951.","journal-title":"J Infect Dis"},{"key":"458_CR17","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1017\/S0031182000075363","volume":"105","author":"GAT Targett","year":"1992","unstructured":"Targett GAT: Malaria \u2013 Drug-Use and the Immune-Response. Parasitology. 1992, 105: S61-S70.","journal-title":"Parasitology"},{"key":"458_CR18","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1086\/345363","volume":"186","author":"DJ Terlouw","year":"2002","unstructured":"Terlouw DJ, Aidoo MA, Udhayakumar V, Kolczak MS, Oloo AJ, Kager PA, Lal AA, Nahlen BL, ter Kuile FO: Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in western Kenya. J Infect Dis. 2002, 186: 1661-1668. 10.1086\/345363.","journal-title":"J Infect Dis"},{"key":"458_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1365-3024.2000.00340.x","volume":"22","author":"V Robert","year":"2000","unstructured":"Robert V, Roeffen W, Brasseur P, Aribot G, Verhave JP, Roussilhon C: Anti-NANP antibody and treatment efficacy in patients with acute uncomplicated falciparum malaria attacks. Parasite Immunol. 2000, 22: 589-593. 10.1046\/j.1365-3024.2000.00340.x.","journal-title":"Parasite Immunol"},{"key":"458_CR20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4269\/ajtmh.2001.65.918","volume":"65","author":"M Mayxay","year":"2001","unstructured":"Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S, White NJ: Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am J Trop Med Hyg. 2001, 65: 918-923.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1086\/368414","volume":"187","author":"DP Mawili-Mboumba","year":"2003","unstructured":"Mawili-Mboumba DP, Borrmann S, Cavanagh DR, McBride JS, Matsiegui PB, Missinou MA, Kremsner PG, Ntoumi F: Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in gabonese children with P-falciparum malaria. J Infect Dis. 2003, 187: 1137-1141. 10.1086\/368414.","journal-title":"J Infect Dis"},{"key":"458_CR22","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/IAI.74.5.2887-2893.2006","volume":"74","author":"M Pinder","year":"2006","unstructured":"Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, Mccall MBB, Ord R, Hallett R, Holder AA, Milligan P: Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in gambian children. Infect Immun. 2006, 74: 2887-2893. 10.1128\/IAI.74.5.2887-2893.2006.","journal-title":"Infect Immun"},{"key":"458_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.meegid.2006.07.001","volume":"7","author":"A Aubouy","year":"2007","unstructured":"Aubouy A, Migot-Nabias F, Deleron P: Correlations between treatment outcome and both anti-MSP1 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria. Infect Genet Evol. 2007, 7: 147-154. 10.1016\/j.meegid.2006.07.001.","journal-title":"Infect Genet Evol"},{"key":"458_CR24","volume-title":"WHO: Geneva","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO: Geneva. 2003"},{"key":"458_CR25","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/AAC.47.4.1347-1354.2003","volume":"47","author":"RJ Pearce","year":"2003","unstructured":"Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother. 2003, 47: 1347-1354. 10.1128\/AAC.47.4.1347-1354.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"458_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0035-9203(99)90120-7","volume":"93","author":"G Snounou","year":"1999","unstructured":"Snounou G, Zhu XP, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S: Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg. 1999, 93: 369-374. 10.1016\/S0035-9203(99)90120-7.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"458_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.2005.72.155","volume":"72","author":"M Alifrangis","year":"2005","unstructured":"Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, Nkya WMMM, Ronn AM, Theander TG, Bygbjerg IC: A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology. Am J Trop Med Hyg. 2005, 72: 155-162.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2875-4-61","volume":"4","author":"A Enevold","year":"2005","unstructured":"Enevold A, Vestergaard LS, Lusingu J, Drakeley CJ, Lemnge MM, Theander TG, Bygbjerg IC, Alifrangis M: Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method. Malar J. 2005, 4: 61-10.1186\/1475-2875-4-61.","journal-title":"Malar J"},{"key":"458_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2141.2000.01870.x","volume":"108","author":"YT Liu","year":"2000","unstructured":"Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB: Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000, 108: 295-299. 10.1046\/j.1365-2141.2000.01870.x.","journal-title":"Br J Haematol"},{"key":"458_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.0300-9475.2004.01409.x","volume":"59","author":"LJM Carvalho","year":"2004","unstructured":"Carvalho LJM, Oliveira SG, Theisen M, Alves FA, Andrade MCR, Zanini GM, Brigido MCO, Oeuvray C, Povoa MM, Muniz JAPC: Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol. 2004, 59: 363-372. 10.1111\/j.0300-9475.2004.01409.x.","journal-title":"Scand J Immunol"},{"key":"458_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/CDLI.2.1.30-34.1995","volume":"2","author":"M Theisen","year":"1995","unstructured":"Theisen M, Vuust J, Gottschau A, Jepsen S, Hogh B: Antigenicity and Immunogenicity of Recombinant Glutamate-Rich Protein of Plasmodium-Falciparum Expressed in Escherichia-Coli. Clin Diagn Lab Immunol. 1995, 2: 30-34.","journal-title":"Clin Diagn Lab Immunol"},{"key":"458_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3121\/cmr.4.1.1","volume":"4","author":"FS Tour\u00e9","year":"2006","unstructured":"Tour\u00e9 FS, Deloron P, Migot-Nabias F: Analysis of Human Antibodies to Erytrhocyte Binding Antigen 175 Peptide 4 of Plasmodium falciparum. Clin Med Res. 2006, 4: 1-6.","journal-title":"Clin Med Res"},{"key":"458_CR33","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1128\/IAI.70.8.4471-4476.2002","volume":"70","author":"CHM Kocken","year":"2002","unstructured":"Kocken CHM, Withers-Martinez C, Dubbeld MA, van der Wel A, Hackett F, Blackman MJ, Thomas AW: High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun. 2002, 70: 4471-4476. 10.1128\/IAI.70.8.4471-4476.2002.","journal-title":"Infect Immun"},{"key":"458_CR34","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1016\/j.vaccine.2006.04.069","volume":"24","author":"S Bonnet","year":"2006","unstructured":"Bonnet S, Petres S, Holm I, Fontaine T, Rosario S, Roth C, Longacre S: Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate. Vaccine. 2006, 24: 5997-6008. 10.1016\/j.vaccine.2006.04.069.","journal-title":"Vaccine"},{"key":"458_CR35","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20040274","volume":"199","author":"ATR Jensen","year":"2004","unstructured":"Jensen ATR, Magistrado P, Sharp S, Joergensen L, Lavstsen T, Chiucciuini A, Salanti A, Vestergaard LS, Lusingu JP, Hermsen R: Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med. 2004, 199: 1179-1190. 10.1084\/jem.20040274.","journal-title":"J Exp Med"},{"key":"458_CR36","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1128\/IAI.01187-06","volume":"74","author":"L Joergensen","year":"2006","unstructured":"Joergensen L, Turner L, Magistrado P, Dahlback MA, Vestergaard LS, Lusingu JP, Lemnge M, Salanti A, Theander TG, Jensen ATR: Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family. Infect Immun. 2006, 74: 6778-6784. 10.1128\/IAI.01187-06.","journal-title":"Infect Immun"},{"key":"458_CR37","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/IAI.63.10.4034-4038.1995","volume":"63","author":"B Hogh","year":"1995","unstructured":"Hogh B, Marbiah NT, Burghaus PA, Andersen PK: Relationship Between Maternally Derived Anti-Plasmodium Falciparum Antibodies and Risk of Infection and Disease in Infants Living in An Area of Liberia, West-Africa, in Which Malaria Is Highly Endemic. Infect Immun. 1995, 63: 4034-4038.","journal-title":"Infect Immun"},{"key":"458_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/(SICI)1097-0320(19990401)35:4<329::AID-CYTO5>3.0.CO;2-Y","volume":"35","author":"T Staalsoe","year":"1999","unstructured":"Staalsoe T, Giha HA, Dodoo D, Theander TG, Hviid L: Detection of antibodies to variant antigens on Plasmodium falciparum \u2013 infected erythrocytes by flow cytometry. Cytometry. 1999, 35: 329-336. 10.1002\/(SICI)1097-0320(19990401)35:4<329::AID-CYTO5>3.0.CO;2-Y.","journal-title":"Cytometry"},{"key":"458_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0035-9203(96)90129-7","volume":"90","author":"AM Ronn","year":"1996","unstructured":"Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC: High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996, 90: 179-181. 10.1016\/S0035-9203(96)90129-7.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"458_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(01)06344-9","volume":"358","author":"T Mutabingwa","year":"2001","unstructured":"Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W: Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet. 2001, 358: 1218-1223. 10.1016\/S0140-6736(01)06344-9.","journal-title":"Lancet"},{"key":"458_CR41","volume-title":"Malar J","author":"K Mugittu","year":"2005","unstructured":"Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B: Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J. 2005, 4:"},{"key":"458_CR42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/AAC.44.4.991-996.2000","volume":"44","author":"AM Nzila","year":"2000","unstructured":"Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM: Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum : Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother. 2000, 44: 991-996. 10.1128\/AAC.44.4.991-996.2000.","journal-title":"Antimicrob Agents Chemother"},{"key":"458_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bjorkman A: Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol. 2006, 6: 309-314. 10.1016\/j.meegid.2005.09.001.","journal-title":"Infect Genet Evol"},{"key":"458_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1128\/IAI.72.1.247-252.2004","volume":"72","author":"S Soe","year":"2004","unstructured":"Soe S, Theisen M, Roussilhon C, Khin SA, Druilhe P: Association between protection, against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendernicity in myanmar: Complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun. 2004, 72: 247-252. 10.1128\/IAI.72.1.247-252.2004.","journal-title":"Infect Immun"},{"key":"458_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/509806","volume":"195","author":"SD Polley","year":"2007","unstructured":"Polley SD, Tetteh KKA, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ: Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis. 2007, 195: 279-287. 10.1086\/509806.","journal-title":"J Infect Dis"},{"key":"458_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4269\/ajtmh.1992.46.307","volume":"46","author":"B Hogh","year":"1992","unstructured":"Hogh B, Petersen E, Dziegiel M, David K, Hanson A, Borre M, Holm A, Vuust J, Jepsen S: Antibodies to A Recombinant Glutamate-Rich Plasmodium-Falciparum Protein \u2013 Evidence for Protection of Individuals Living in A Holoendemic Area of Liberia. Am J Trop Med Hyg. 1992, 46: 307-313.","journal-title":"Am J Trop Med Hyg"},{"key":"458_CR47","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1086\/315341","volume":"181","author":"D Dodoo","year":"2000","unstructured":"Dodoo D, Theisen M, Kurtzhals JAL, Akanmori BD, Koram KA, Jepsen S, Nkrumah FK, Theander TG, Hviid L: Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis. 2000, 181: 1202-1205. 10.1086\/315341.","journal-title":"J Infect Dis"},{"key":"458_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/IAI.66.1.11-17.1998","volume":"66","author":"M Theisen","year":"1998","unstructured":"Theisen M, Soe S, Oeuvray C, Thomas AW, Vuust J, Danielsen S, Jepsen S, Druilhe P: The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun. 1998, 66: 11-17.","journal-title":"Infect Immun"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-6-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-6-153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-6-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T03:01:26Z","timestamp":1588042886000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-6-153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,16]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-6-153","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,16]]},"article-number":"153"}}